These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5860955)

  • 21. [Reactogenic and immunogenic properties of a live measles vaccine according to observations in Latvia].
    Vasil'ev KG; Zvezdova SF; Feoktistova RP
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():225-9. PubMed ID: 5860943
    [No Abstract]   [Full Text] [Related]  

  • 22. [Reactogenic properties of the Leningrad-4 measles vaccine according to data from Moldavia].
    Revenok ND; Bondurianskiĭ IP; Grozman IaG; Groĭsman GM; Lebenzon NP; Shroĭt IG; Bulychev NT
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():166-74. PubMed ID: 4222060
    [No Abstract]   [Full Text] [Related]  

  • 23. [Nature of reactogenic properties of the measles vaccine of the Pasteur Institute of Epidemiology and Microbiology in Leningrad].
    Netsvetaeva TD
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():222-4. PubMed ID: 5860942
    [No Abstract]   [Full Text] [Related]  

  • 24. [Data on active immunization against measles in the city of Odessa and in the Odessa region].
    Irodoĭ MA; Bogdanova AP; Levenshtam MA; Shvets NG; Angeli-Baĭbarova RN
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():379-84. PubMed ID: 5863068
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effectiveness of the use of live measles vaccine (LMV) in the Ukrainian SSR].
    Zelinskiĭ AN; Siniak KM
    Vrach Delo; 1974 Feb; (2):1-6. PubMed ID: 4468597
    [No Abstract]   [Full Text] [Related]  

  • 26. [Time of the appearance of immunity to measles after the administration of a live measles vaccine].
    Revenok ND
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():355-60. PubMed ID: 5860953
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of the vaccination against measles with a use of a live vaccine in Rowno and in Rowno district].
    Levchenko IF
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():411-5. PubMed ID: 5860961
    [No Abstract]   [Full Text] [Related]  

  • 28. [The nature of some reactogenic properties of a live measles vaccine].
    Kurashvili VE; Meparishvili KG; Mateshvili ES
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():197-205. PubMed ID: 5317833
    [No Abstract]   [Full Text] [Related]  

  • 29. [Reactivity to live measles vaccine of the ESHCH strain of the Academy of Medical Sciences, RSFS].
    Tsipershteĭn MIa
    Pediatr Akus Ginekol; 1970; 4():25-6. PubMed ID: 5504822
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on the immunologic activity of live measles vaccine AMN USSR from strain ESHCH according the material of Ukrainian SSR].
    Voroshylova MK; Chumakov MP; Syniak KM; Ralko LP; Romanenko VF; Rodin VI; Khozynskyĭ VI; Uryryn AI; Chudnaia LM; Lebedieva IR
    Pediatr Akus Ginekol; 1968 Jan; 1():24-5. PubMed ID: 5669027
    [No Abstract]   [Full Text] [Related]  

  • 31. [Electroencephalographic and clinical observations in active measles vaccination with attenuated live vaccine].
    Müller K; Eckoldt G
    Dtsch Gesundheitsw; 1966 Jan; 21(2):70-6. PubMed ID: 5940860
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on biological, reactogenic and immunogenic properties of a new variant of a live measles vaccine prepared from the Leningrad-5 strain].
    Denisov GM; Boĭchuk LM; Shikina ES
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():78-86. PubMed ID: 5860964
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaccination against measles: a clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. A report to the Medical Research Council by the Measles Vaccines Committee.
    Br Med J; 1966 Feb; 1(5485):441-6. PubMed ID: 5902680
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immuno-epidemiological effectiveness of Beckenham's measles vaccine].
    Topciu V; Arion R; Moldovan E; Olaru G; Csaky N; Băcilă E; Halasz C; Weitzen O; Dan G; Mîrza I; Magyorosi E; Jeremias N; Nicolau D; Yampan R
    Stud Cercet Virusol; 1972; 23(2):145-50. PubMed ID: 4646494
    [No Abstract]   [Full Text] [Related]  

  • 35. Edmonston-Zagreb strain of measles vaccine: epidemiologic evaluation in Yugoslavia.
    Ikić DM
    Rev Infect Dis; 1983; 5(3):558-63. PubMed ID: 6879014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Results of the first trials of measles vaccination in France, with the hyperattenuated live cirus vaccine (Schwartz strain)].
    Mande R; Jammet ML; Celers J; Boué A
    Arch Fr Pediatr; 1967 Jan; 24(1):105-6. PubMed ID: 6031447
    [No Abstract]   [Full Text] [Related]  

  • 37. [Specific prophylaxis in measles. II. Tests with children of a vaccine prepared with transformed live virus (strain M60-5 Huang)].
    Cajal N; Cepleanu M; Sorodoc Y; Ionescu S; Gartner M; Ianopol L; Boghiţoiu G; Friedman O; Huluţă L; Ionescu D
    Stud Cercet Inframicrobiol; 1966; 17(5):377-87. PubMed ID: 5964006
    [No Abstract]   [Full Text] [Related]  

  • 38. [Vaccination against measles].
    Cocchi P; Corti R
    Pediatr Med Chir; 1984; 6(1):5-11. PubMed ID: 6085156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measles outbreak in western Sydney. Vaccine failure or failure to vaccinate?
    McDonnell LF; Jorm LR; Patel MS
    Med J Aust; 1995 May; 162(9):471-5. PubMed ID: 7746203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation of the time-dependent vaccine efficacy from a measles epidemic.
    Eichner M; Diebner HH; Schubert C; Kreth HW; Dietz K
    Stat Med; 2002 Aug; 21(16):2355-68. PubMed ID: 12210620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.